Prof Hift’s Publications

The neurological manifestations of the acute porphyrias.

Sonderup MW, Hift RJ.

S Afr Med J. 2014 Apr;104(4):285-6. 

PMID: 25118552

The spectrum of skin diseases in a black population in Durban, KwaZulu-Natal, South Africa.

Dlova NC, Mankahla A, Madala N, Grobler A, Tsoka-Gwegweni J, Hift RJ.

Int J Dermatol. 2014 Apr 16. doi: 10.1111/ijd.12589. 

PMID: 24738608

 Iron homeostasis in porphyria cutanea tarda: mutation analysis of promoter regions of CP, CYBRD1, HAMP and SLC40A1.

Panton NA, Strickland NJ, Hift RJ, Warnich L, Zaahl MG.

J Clin Pathol. 2013 Feb;66(2):160-1. doi: 10.1136/jclinpath-2012-200988. Epub 2012 Sep 25. 

PMID: 23012398

Fifty years of porphyria at the University of Cape Town.

Meissner PN, Corrigall AV, Hift RJ.

S Afr Med J. 2012 Mar 2;102(6):422-6.

PMID: 22668925

A review of the clinical presentation, natural history and inheritance of variegate porphyria: its implausibility as the source of the ‘Royal Malady’.

Hift RJ, Peters TJ, Meissner PN.

J Clin Pathol. 2012 Mar;65(3):200-5. doi: 10.1136/jclinpath-2011-200276. Epub 2011 Nov 2. 

PMID: 22049218

Porphyria cutanea tarda, iron, inflammation and diabetes mellitus.

Hift RJ.

Br J Dermatol. 2011 Sep;165(3):453-4. doi: 10.1111/j.1365-2133.2011.10518.x. 


Drugs in porphyria: From observation to a modern algorithm-based system for the prediction of porphyrogenicity.

Hift RJ, Thunell S, Brun A.

Pharmacol Ther. 2011 Nov;132(2):158-69. doi: 10.1016/j.pharmthera.2011.06.001. Epub 2011 Jun 16. 

PMID: 21704073

Share This Page